Home > Income Statement > BETA DRUGS

BETA DRUGS
Consolidated Net Profit

    Back to Income Statement
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹42 Cr₹36 Cr₹31 Cr₹25 Cr₹12 Cr

What is the latest Consolidated Net Profit of BETA DRUGS ?

The latest Consolidated Net Profit ratio of BETA DRUGS is ₹42 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹42 Cr
Mar2024₹36 Cr
Mar2023₹31 Cr
Mar2022₹25 Cr
Mar2021₹12 Cr

How is Consolidated Net Profit of BETA DRUGS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹42 Cr
16.42
Mar2024 ₹36 Cr
18.61
Mar2023 ₹31 Cr
23.73
Mar2022 ₹25 Cr
111.75
Mar2021 ₹12 Cr -

Compare Consolidated Net Profit of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,315.2 Cr -6% -18.5% 10.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,236.0 Cr -1.8% -3.7% 17.2% Stock Analytics
DIVIS LABORATORIES ₹249,673.0 Cr 3.4% 10.1% 57.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,460.0 Cr 1.6% 0.8% 37.8% Stock Analytics
CIPLA ₹111,484.0 Cr -0.4% -5.6% -11.9% Stock Analytics
DR REDDYS LABORATORIES ₹95,220.3 Cr -1.1% -4.9% -9.9% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-6%

-18.5%

10.9%

SENSEX

-1.6%

-4.2%

-7.2%


You may also like the below Video Courses